You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

AREDIA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Aredia patents expire, and what generic alternatives are available?

Aredia is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in AREDIA is pamidronate disodium. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pamidronate disodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aredia

A generic version of AREDIA was approved as pamidronate disodium by HIKMA on April 30th, 2001.

  Try a Trial

Drug patent expirations by year for AREDIA
Recent Clinical Trials for AREDIA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ottawa Hospital Research InstitutePhase 4
Masonic Cancer Center, University of MinnesotaPhase 2
AmgenPhase 4

See all AREDIA clinical trials

US Patents and Regulatory Information for AREDIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-001 Oct 31, 1991 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-003 May 6, 1993 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-004 May 6, 1993 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for AREDIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-001 Oct 31, 1991 ⤷  Try a Trial ⤷  Try a Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-004 May 6, 1993 ⤷  Try a Trial ⤷  Try a Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-001 Oct 31, 1991 ⤷  Try a Trial ⤷  Try a Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-004 May 6, 1993 ⤷  Try a Trial ⤷  Try a Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-003 May 6, 1993 ⤷  Try a Trial ⤷  Try a Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-003 May 6, 1993 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for AREDIA

See the table below for patents covering AREDIA around the world.

Country Patent Number Title Estimated Expiration
Netherlands 7414947 ⤷  Try a Trial
Spain 555602 ⤷  Try a Trial
Argentina 244698 PROCEDIMIENTO PARA OBTENER UNA NUEVA MODIFICACION CRISTALINA DEL 3-AMINO-1-HIDROXI-1,1-DIFOSFONATO DISODICO. (CRYSTAL MODIFICATION OF DISODIUM-3-AMINO-1-HYDROXY-PROPANE-1,1- DIPHOSPHONATE) ⤷  Try a Trial
Denmark 167282 ⤷  Try a Trial
Italy 1058296 PREPARATO COSEMTICO A BASE DI AGENTI PER LA CURA DELLA BOCCA E DEI DENTI CHE CONTENGONO UN ACIDO AMMINOALCAREDIFOSFONICO OPPURE I SUOI SALI IDROSOLUBILI ⤷  Try a Trial
Norway 165401 ⤷  Try a Trial
Hong Kong 42591 CRYSTAL MODIFICATION OF DISODIUM-3-AMINO-1-HYDROXY-PROPANE-1,1-DIPHOSPHONATE ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.